Why everyone's talking about MEDVi for weight loss, and why you should too MEDVi is a telehealth platform offering GLP-1 weight loss medications, including both FDA-approved and compounded versions
See your weight loss physician for a consultation as the starting dose may change
Logistic regression was performed using both Python (Python Software Foundation, Wilmington, Delaware, USA) and R 3.4.4 software (R Foundation for Statistical Computing, Vienna, Austria) to ensure the outputs matched, and the order of the rows in the covariate matrix was randomised to eliminate this bias
Design, fabrication, and analysis of silicon microneedles for transdermal drug delivery applications
No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia
Participants on retatrutide measured reduced visceral fat after weeks, with changes monitored via MRI